1
H, 13 C and 19 F NMR data were recorded on Bruker Ascend TM 400 or DMX 500 instruments. Chemical shifts are reported as δ values (ppm) with (residual) solvent internal standard. 19 F NMR signals were referenced to hexafluorobenzene (δ = -161.75 in CDCl 3 or -162.65 in DMSO-d 6 ) unless noted otherwise. High resolution electrospray ionization (HRMS-ESI) mass spectrometry data were obtained from Proteoomika tuumiklabor at the University of Tartu, Estonia, or from the Mass Spectrometry Lab at the University of Illinois at Urbana-Champaign. IR spectra were recorded with a ReactIR TM IC10 (Mettler Toledo Co.) for liquid samples, or a SPECTRUM 2000 (Perkin Elmer) for solid samples in the ATR mode.
Fluorescence spectra were recorded on a Varian Cary Eclipse fluorescence spectrophotometer. Particle size measurements were performed on a Malvern Zetasizer Nano ZS with a backscattering angle of 173 o . Transmission electron microscopy (TEM) images were obtained on a Phillips EM-400 TEM microscope operating at an accelerating voltage of 100 kV. Thermogravimetric analysis (TGA) was carried on a TA instrument (Q-50 series). Analysis of TGA data followed previously reported method. 1 XPS spectra were taken on a Surface Science Instruments S-probe spectrometer. 2 This instrument has a monochromatized Al Kα X-ray and a low energy electron flood gun for charge neutralization of non-conducting samples. All samples were then mounted to the sample holder with double sided tape and run as insulators. The X-ray spot size for these acquisitions was approximately 800 μm. Pressure in the analytical chamber during spectral acquisition was less than 5 x 10 -9 Torr. The pass energy for survey spectra (to calculate composition) was 150 eV and pass energy for high resolution scans was 50 eV. The Service Physics ESCA Hawk data analysis software was used to determine peak areas, to calculate the elemental compositions from peak areas above a linear background, and to peak fit the high resolution spectra. The binding energy scales of the high-resolution spectra were
Electronic Supplementary Material (ESI) for Materials Chemistry Frontiers. This journal is © the Partner Organisations 2018
S2 calibrated by assigning the lowest binding energy of the C1s high-resolution component at 285.0 eV. Three spots were analyzed on each sample.
COMPOUND SYNTHESIS AND CHARACTERIZATION
General procedure for amidine synthesis. To a solution of an aldehyde (0.55 mmol) and an amine (0.55 mmol) in solvent (0.5 mL), the azide (0.50 mmol) in solvent (0.5 mL) was added dropwise while stirring. The reaction was followed by 1 H NMR by taking an aliquot (20 μL) of the crude solution and diluted in CDCl 3 (500 μL). When NMR indicated full conversion, silica gel (200 mg) was added to the reaction mixture and the mixture was dried under reduced pressure. When DMSO and DMF were used as the reaction solvent, the reaction mixture was added to the column directly. The crude product was further purified by flash column chromatography. 2,3,5,6-tetrafluoro-4-((2-phenyl-1-(piperidin-1-yl) ethylidene)amino)benzoate (5a). 3 White solid (363 mg, 89%). R f = 0.27 (hexanes/EtOAc = 9:1). 1 
Methyl (E)-

Methyl (E)-2,3,5,6-tetrafluoro-4-((2-phenyl-1-(pyrrolidin-1-yl)ethylidene)amino)benzoate (5c).
3 White solid (383 mg, 97%). R f = 0.20 (Hexanes/EtOAc = 9:1). 
Methyl (E)-2,3,5,6-tetrafluoro-4-((2-phenyl-1-(phenylamino)ethylidene)amino)benzoate (5g)
. To a solution of phenylacetaldehyde (2.5 mmol) and azide (2.0 mmol) in MeOH (6 mL), aniline (2.5 mmol) in MeOH (2 mL) was added dropwise at 40 o C. When NMR indicated full conversion (~12 h), silica gel (1.3 g) was added to the reaction mixture and the mixture was dried under reduced pressure. The crude product was further purified by flash column chromatography using hexanes/EtOAc 4:1 (R f = 0.31) as eluent to provide the title compound as a pale yellow solid (337 mg, 81% 
Methyl (E)-4-((1-(diphenylamino)
-
Methyl (E)-2,3,5,6-tetrafluoro-4-((1-(piperidin-1-yl)butylidene)amino)benzoate (5i)
. To a solution of aldehyde (1.2 mmol) and azide (1.0 mmol) in MeOH (6 mL), piperidine (1.1 mmol) in MeOH (2 mL) was added dropwise while stirring at 40 o C. When NMR indicated full conversion (~4 h), silica gel (0.8 g) was added to the reaction mixture. The mixture was dried under reduced pressure. The obtained crude product was further purified by flash column chromatography using hexanes/EtOAc 9:1 (R f = 0.32) as the eluent to provide the title compounds as a white solid (310 mg, 85%). CIP-PFAA. Azide 1 (250 mg, 1.0 mmol), phenylacetaldehyde (132 mg, 1.1 mmol) and ciprofloxacin (183 mg, 0.5 mmol) were mixed in acetone (100 mL), and stirred at r.t. until the solution became clear (~ 3 days). Acetone was removed and the solid was further extracted from 0.5 M HCl using DCM. The organic phase was dried over Na 2 SO 4 , and the solvent was evaporated. The crude was further purified by flash column chromatography (25:1 DCM/methanol, R f = 0.25) to provide the title compound as a pale yellow solid (294 mg, 90% NOR-PFAA. Pentafluorophenyl azide (250 mg, 1.2 mmol), phenylacetaldehyde (132 mg, 2.1 mmol) and norfloxacin (333 mg, 1.0 mmol) were mixed in acetone (60 mL), and stirred at r.t. until it became clear (~ 24 h). Acetone was removed and the crude was extracted from 0.5 M HCl using DCM and the organic phase was dried over Na 2 SO 4 , and solvent was evaporated. The crude was further purified by flash column chromatography (20:1 DCM/MeOH, R f = 0.22) to provide the title compound as a pale yellowish solid (495 mg, 82%). (1a) 4 (3.86 g, 15.49 mmol) was dissolved in mixture of MeOH (15 mL), aqueous sodium hydroxide solution (20 w%, 3 mL) and water (3 mL). The mixture was stirred until TLC indicated full conversion. The mixture was then acidified with 1 M aqueous HCl and extracted with DCM (3 x 60 mL). The solvent was evaporated under reduced pressure to yield 4-azido-2,3,5,6-tetrafluorobenzoic acid as a white solid (quant.). 4-Azido-2,3,5,6-tetrafluorobenzoic acid (933 mg, 3.97 mmol), N-hydroxysuccinimide (502 mg, 4.36 mmol), and EDAC (836 mg, 4.36 mmol) were dissolved in DCM (15 mL) and stirred for 22 h at room temperature. Additional EDAC (433 mg, 2.26 mmol) was added, and the mixture was stirred for another 8 h. When NMR indicated a full conversion, the mixture was diluted with water and extracted twice with DCM. The combined organic phase was washed with water, dried over MgSO 4 , and evaporated under reduced pressure to give compound 12 as white crystals. A solution of compound 12 (102.8 mg, 3.1 mmol), 3-aminopropyltimethoxysilane 13 (3.7 mmol) in DCM (4 mL) was capped in N 2 and stirred for 5 h at room temperature. Afterwards, the mixture was evaporated and approximately 0.3 g of silica gel was added to the dried residue. This crude was purified by column chromatography on silica gel using 1:3 v/v chloroform/hexanes containing 2% methanol as an eluent. Evaporation of the solvent gave compound 14 as a colorless viscous liquid (98 mg, 88%). 
Methyl (E)-2,3,5,6-tetrafluoro-4-((2-methyl-1-(piperidin-1-yl)propylidene)amino)benzoate (5k
.3, 112.5, 119.9, 120.0, 127.4, 127.7, 129.3, 134.2, 134.4 (tt, 1C, J CF = 14, 3 Hz), 139.0, 139.9 (dm, 2C, J CF = 240 Hz), 145.3, 145.4, 145.8 (dm, 2C, J CF = 256 Hz), 147.5, 152.3, 154.8, 160.3, 161.1, 166.9, 177.0 (d, 1C, J = 3 Hz); 19 F NMR (376 MHz, CDCl 3 ): δ -121.17 (s, 1F), -140.81 (m, 2F), -152.91 (m, 2F); ESI-HRMS: Calcd. for C
SYNTHESIS OF FUNCTIONALIZED SILICA NANOPARTICLES (SNPs)
PFAA-functionalized SNPs (PFAA-SNPs)
A reported protocol was used to prepare silica nanoparticles (SNPs) of ~50 nm size. 5, 6 Ammonium hydroxide (28% in water, 1 mL) and ethanol (95%, 40 mL) were added into a three-necked round-bottom flask at 40 °C, then TEOS (0.5 mL) was added into the flask slowly. After stirring for 48 h, the nanoparticles were isolated by centrifugation. The sediments were redispersed in ethanol and the mixture was centrifuged again. This purification cycle was repeated three times. The obtained nanoparticles were then dried under vacuum.
To prepare 90 nm SNPs, 1,7-9 ammonium hydroxide (28%, 15 mL) was dissolved in ethanol (250 mL) in a threenecked round-bottom flask at 30 °C. A solution of TEOS (10 mL) in ethanol (10 mL) was added dropwise into the flask, and the resulting mixture stirred for 24 h. The reaction mixture was centrifuged at 7500 rpm for 20 min, and the sediments were washed with ethanol. The washing was repeated three times, and the resulting silica nanoparticles were dried under vacuum at 50 °C.
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To functionalize SNPs with PFAA, 10 a mixture of PFPA-silane 14 (219 mg, 0.5 mmol) and SNPs (200 mg) for 50 nm (400 mg for 90 nm sized SNPs) in dry toluene (10 mL) was stirred at 70 °C for 16 h. The obtained nanoparticles were collected by centrifugation and washed two times with toluene and ethanol (7500 rpm, 20 min), respectively. The obtained PFPA-SNPs were dried under vacuum.
Fluoroquinolone-functionalized SNPs
Synthesis of CIP-SNPs. PFPA-functioned silica nanoparticles (PFAA-SNPs, 100 mg), (88 ± 10 nm by TEM) were sonicated in acetone (20 mL). Ciprofloxacin (10 mg) and phenylacetaldehyde (10 mg) were added and the mixture was first sonicated and then vigorously stirred at room temperature in the dark. To monitor the reaction progress, 400 μL aliquots of the above mixture was diluted to 1.25 mL acetone at defined time point. The mixture was sonicated and then centrifuged at 11000 rpm for 15 minutes to remove the supernatant. The washing protocol was repeated sequentially in acetone, acidic water, acetone, water, acetone and water. The supernatants in every washing cycle were checked with fluorescence spectroscopy and IR to make sure that free ciprofloxacin had been washed off. Surface-modified particles had a much improved dispersibility in water. The reaction process was monitored using the above purified samples by both the fluorescence (emission: 450-470 nm, excitation: 335 nm) and IR spectroscopy (azido peak at 2130 cm -1 ). After 24 hours, the IR and fluorescence spectra of isolated samples both showed a high degree of conversion. The immobilization was extended up to 7 days. For this specific sample showing in Fig. S6 , the workup was done at 100 hours. The purification was done by repeated centrifugationwashing using different solvents above, and the isolated supernatant solutions were checked with fluorescence and IR spectra to ensure the removal of unreacted ciprofloxacin. After drying under vacuum for 2 days, the functionalized particles (CIP-SNPs, 80 mg) were collected as a white powder, which showed fluorescence under UVlight.
NOR-SNPs were synthesized in analogy to CIP-SNPs.
ANTIBACTERIAL ACTIVITY TESTS
E. coli ORN208 was grown to 0.3 OD 600 (~10 8 CFU/mL), which was then diluted 100 fold to ~10 6 CFU/mL. The aqueous suspension of samples (compounds, particle samples: PFAA-SNPs, CIP-SNPs and NOR-SNPs) was diluted sequentially to give a concentration series. The suspension (100 μL) was added to the diluted bacteria (100 μL) in a 96 well plate (in triplicates), and incubated at 37 o C for 18 h. Alamar blue dye (20 μL) was added to each sample, which was incubated for an additional 2 h. Fluorescence intensities at 590 nm (excitation: 560 nm) were recorded for the MIC analysis.
CONFOCAL FLUORESCENT IMAGING OF CIP-FSNPs
E. coli ORN208 was incubated overnight in Mueller-Hinton broth at 37 °C with shaking at 110/min (VWR Rocker adjustable double platform). The bacteria were then transferred to new culture medium and cultured for another 3 h, and the OD620 were measured to be 0.209. Afterwards, the bacteria were pelleted (4000 rpm, 15 min) and redispersed in pH 7.4 PBS to an OD 620 of 0.074 (~10 8 CFU/mL). CIP-FSNPs were dispersed in millipore water (0.5 mg/mL) by strong sonication, and then portions of the stock solution were added to a 1.00 mL aliquot of the bacteria suspension. The final concentration of silica nanoparticles were 0.1 mg/ml and 0.01 mg/ml, respectively. The mixtures were further incubated at 37 °C for 4 h while shaking at 100/min. An aliquot of the suspension (0.100 mL) was spread on a glass-bottom dish. Confocal fluorescence microscopy images were acquired using a Zeiss LSM 780 confocal microscope (Carl Zeiss, Jena, Germany) with a C-Apochromat 40x/1.20 W Korr FCS M27 objective. The microscope was focused on the surface of the glass-bottom dish where live bacteria transiently sedimented before they migrated away. 405 and 488 nm excitation sources were used for imaging experiments.
KINETIC ANALYSIS
Estimation of rate constants
The enamine-azide reactions was assumed to proceed in two-steps: cycloaddition followed by decomposition.
The cycloaddition rate constant k 1 was estimated through the second-order combined formation of C and D over time (see below), and the decomposition rate constant k 2 was accessed from the first-order formation of D from C. The transformations were followed by 19 F and 1 H NMR, from which data the constants were estimated through non-linear regression analysis (GraphPad).
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Estimation of cycloaddition rate constant k 1
At t = 0:
At any t:
This gives:
Rearrangement gives:
Integration of eq. 3:
Solving eq. 4:
Kinetics of reaction between PFAA 1a and phenylacetaldehyde piperidine enamine in CD 3 OD Figure S1 . PFAA 1a phenylacetaldehyde piperidine enamine cycloaddition and decomposition in CD 3 
EFFECTS FROM SOLVENT
Perfluoroaryl azide-aldehyde-amine reaction in methanol with different amount of water Figure S2 . Figure S2 .
h Isolated yields of compound 5i, 72 h. Figure S6 . Side reactions leading to triazole 9 and aryl amide 10.
REACTIONS WITH DIFFERENT AMINES
EFFECTS OF ADDED EQUIVALENTS OF ALDEHYDE AND AMINE
SIDE REACTIONS
11-13
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FLUORESCENCE OF CIP-SNPs vs REACTION TIME. 
DLS MEASUREMENT OF SNPs
CIP-SNPs dispersed well in water or acetone, while PFPA-SNPs dispersed well in acetone but not in water. Figure S10 . XPS analysis of PFPA-SNPs.
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XPS ANALYSIS
PFPA-SNPs
CIP-SNPs.
Figure S11. XPS analysis of CIP-SNPs. Figure S12 . TEM images of silica nanoparticle samples.
TEM OF SNPs
